 Eric Pietras
Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 37 | 2025 | 418 | 10.050 |
Why?
| | Hematopoiesis | 15 | 2025 | 193 | 3.270 |
Why?
| | Bone Marrow | 10 | 2024 | 306 | 1.780 |
Why?
| | Stem Cell Niche | 8 | 2025 | 57 | 1.580 |
Why?
| | Dioxygenases | 3 | 2022 | 34 | 1.510 |
Why?
| | Neoplastic Stem Cells | 5 | 2024 | 409 | 1.320 |
Why?
| | Inflammation | 13 | 2025 | 2876 | 1.250 |
Why?
| | Myelodysplastic Syndromes | 4 | 2024 | 148 | 1.180 |
Why?
| | Leukemia | 5 | 2025 | 246 | 1.140 |
Why?
| | Stress, Physiological | 3 | 2021 | 443 | 1.100 |
Why?
| | Proto-Oncogene Proteins | 5 | 2022 | 623 | 1.080 |
Why?
| | Mice | 45 | 2025 | 18303 | 1.060 |
Why?
| | Cell Proliferation | 9 | 2021 | 2504 | 0.970 |
Why?
| | Interferon Type I | 5 | 2014 | 147 | 0.970 |
Why?
| | Cell Cycle | 5 | 2021 | 596 | 0.910 |
Why?
| | Trans-Activators | 3 | 2022 | 396 | 0.870 |
Why?
| | Animals | 57 | 2025 | 37952 | 0.850 |
Why?
| | Cell Differentiation | 12 | 2025 | 2040 | 0.820 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2023 | 27 | 0.760 |
Why?
| | Leukemia, Myeloid | 1 | 2022 | 48 | 0.730 |
Why?
| | Signal Transduction | 17 | 2025 | 5208 | 0.710 |
Why?
| | Multipotent Stem Cells | 3 | 2021 | 21 | 0.710 |
Why?
| | Cell Lineage | 4 | 2021 | 377 | 0.690 |
Why?
| | Epigenesis, Genetic | 3 | 2024 | 672 | 0.650 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2024 | 686 | 0.650 |
Why?
| | Oxidative Phosphorylation | 2 | 2025 | 209 | 0.650 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2022 | 1216 | 0.640 |
Why?
| | Interleukin-1 | 4 | 2023 | 961 | 0.640 |
Why?
| | Endothelial Protein C Receptor | 1 | 2019 | 6 | 0.620 |
Why?
| | Antigens, CD34 | 1 | 2019 | 89 | 0.610 |
Why?
| | Hematologic Diseases | 2 | 2023 | 66 | 0.610 |
Why?
| | Flow Cytometry | 5 | 2021 | 1159 | 0.600 |
Why?
| | Mutation | 12 | 2025 | 4071 | 0.600 |
Why?
| | Mice, Inbred C57BL | 18 | 2025 | 5972 | 0.570 |
Why?
| | Stem Cell Factor | 1 | 2018 | 16 | 0.550 |
Why?
| | DNA-Binding Proteins | 4 | 2022 | 1479 | 0.540 |
Why?
| | Macrophages | 3 | 2024 | 1500 | 0.530 |
Why?
| | Arthritis, Experimental | 1 | 2019 | 136 | 0.520 |
Why?
| | Health | 1 | 2017 | 82 | 0.510 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 766 | 0.510 |
Why?
| | Disease | 1 | 2017 | 96 | 0.490 |
Why?
| | Immunity, Innate | 6 | 2023 | 834 | 0.440 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 468 | 0.430 |
Why?
| | Virus Diseases | 2 | 2008 | 216 | 0.430 |
Why?
| | Monocytes | 2 | 2022 | 537 | 0.420 |
Why?
| | Regeneration | 3 | 2025 | 197 | 0.420 |
Why?
| | Cytokines | 7 | 2020 | 2048 | 0.420 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2021 | 698 | 0.400 |
Why?
| | HMGA2 Protein | 1 | 2013 | 10 | 0.400 |
Why?
| | Myeloid Cells | 3 | 2025 | 146 | 0.380 |
Why?
| | Inflammation Mediators | 2 | 2020 | 506 | 0.370 |
Why?
| | Proto-Oncogene Proteins c-ets | 2 | 2022 | 56 | 0.340 |
Why?
| | Repressor Proteins | 3 | 2025 | 429 | 0.340 |
Why?
| | Receptors, CCR2 | 1 | 2011 | 38 | 0.330 |
Why?
| | Receptors, Interferon | 1 | 2011 | 60 | 0.330 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2011 | 118 | 0.330 |
Why?
| | Francisella tularensis | 1 | 2011 | 33 | 0.330 |
Why?
| | Phosphoproteins | 3 | 2020 | 337 | 0.320 |
Why?
| | DNA | 1 | 2017 | 1433 | 0.320 |
Why?
| | Germ-Line Mutation | 2 | 2022 | 176 | 0.320 |
Why?
| | Aging | 7 | 2025 | 1962 | 0.320 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4552 | 0.310 |
Why?
| | Gene Expression | 5 | 2021 | 1474 | 0.310 |
Why?
| | Humans | 42 | 2025 | 145140 | 0.310 |
Why?
| | Arthritis, Rheumatoid | 1 | 2019 | 1174 | 0.310 |
Why?
| | Host-Pathogen Interactions | 2 | 2021 | 361 | 0.300 |
Why?
| | Neutrophils | 6 | 2025 | 1123 | 0.300 |
Why?
| | RNA Splicing Factors | 2 | 2020 | 66 | 0.300 |
Why?
| | TNF Receptor-Associated Death Domain Protein | 1 | 2008 | 2 | 0.280 |
Why?
| | Neoplasms | 3 | 2022 | 2900 | 0.280 |
Why?
| | Mitochondria | 5 | 2025 | 992 | 0.280 |
Why?
| | Cell Cycle Proteins | 2 | 2011 | 629 | 0.280 |
Why?
| | Stem Cells | 3 | 2022 | 624 | 0.270 |
Why?
| | Mice, Transgenic | 5 | 2023 | 2185 | 0.260 |
Why?
| | Homeostasis | 2 | 2021 | 639 | 0.260 |
Why?
| | Immunity | 1 | 2008 | 140 | 0.260 |
Why?
| | Viruses | 2 | 2008 | 164 | 0.260 |
Why?
| | MicroRNAs | 1 | 2013 | 686 | 0.250 |
Why?
| | Mitochondrial Proteins | 2 | 2008 | 263 | 0.250 |
Why?
| | Reactive Oxygen Species | 2 | 2020 | 611 | 0.240 |
Why?
| | Interleukin-1beta | 3 | 2021 | 390 | 0.240 |
Why?
| | September 11 Terrorist Attacks | 1 | 2025 | 31 | 0.230 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2025 | 23 | 0.220 |
Why?
| | Receptors, Colony-Stimulating Factor | 1 | 2025 | 7 | 0.220 |
Why?
| | Diet, Western | 2 | 2023 | 88 | 0.220 |
Why?
| | Glycolysis | 2 | 2024 | 340 | 0.220 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2025 | 74 | 0.220 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2025 | 30 | 0.220 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 36 | 0.220 |
Why?
| | Semaphorins | 1 | 2025 | 37 | 0.210 |
Why?
| | Bacterial Infections | 1 | 2006 | 246 | 0.200 |
Why?
| | Splicing Factor U2AF | 2 | 2023 | 18 | 0.190 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2022 | 161 | 0.190 |
Why?
| | Apoptosis | 6 | 2025 | 2434 | 0.190 |
Why?
| | Transcriptional Activation | 1 | 2025 | 372 | 0.190 |
Why?
| | B-Lymphocytes | 3 | 2022 | 866 | 0.190 |
Why?
| | Interferon Regulatory Factors | 2 | 2020 | 44 | 0.190 |
Why?
| | fas Receptor | 4 | 2008 | 91 | 0.190 |
Why?
| | Liver | 2 | 2024 | 1893 | 0.180 |
Why?
| | Spliceosomes | 2 | 2020 | 54 | 0.180 |
Why?
| | Leukocytes | 1 | 2024 | 296 | 0.180 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2022 | 92 | 0.180 |
Why?
| | Cholinergic Agents | 1 | 2022 | 18 | 0.180 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2024 | 238 | 0.180 |
Why?
| | Up-Regulation | 3 | 2021 | 846 | 0.180 |
Why?
| | Autoimmunity | 2 | 2025 | 932 | 0.170 |
Why?
| | Mice, Knockout | 6 | 2025 | 3114 | 0.170 |
Why?
| | Receptors, Notch | 2 | 2020 | 90 | 0.170 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2021 | 37 | 0.170 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2022 | 337 | 0.170 |
Why?
| | Nuclear Receptor Co-Repressor 2 | 1 | 2020 | 11 | 0.160 |
Why?
| | Myelopoiesis | 2 | 2018 | 10 | 0.160 |
Why?
| | Clone Cells | 1 | 2021 | 263 | 0.160 |
Why?
| | Bone Marrow Diseases | 1 | 2020 | 20 | 0.160 |
Why?
| | Carcinogenesis | 1 | 2022 | 227 | 0.160 |
Why?
| | DNA Damage | 2 | 2021 | 435 | 0.160 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 109 | 0.160 |
Why?
| | Drug Therapy | 1 | 2020 | 84 | 0.160 |
Why?
| | Cellular Reprogramming | 3 | 2017 | 98 | 0.160 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2021 | 76 | 0.150 |
Why?
| | Bacteria | 1 | 2006 | 765 | 0.150 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 166 | 0.150 |
Why?
| | Staphylococcus aureus | 3 | 2010 | 451 | 0.150 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 296 | 0.140 |
Why?
| | Histone Deacetylases | 1 | 2020 | 207 | 0.140 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2019 | 27 | 0.140 |
Why?
| | Darkness | 1 | 2018 | 26 | 0.140 |
Why?
| | Thrombocytopenia | 1 | 2020 | 204 | 0.140 |
Why?
| | Interferon Inducers | 1 | 2018 | 9 | 0.140 |
Why?
| | Cells, Cultured | 5 | 2021 | 4142 | 0.130 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 211 | 0.130 |
Why?
| | Poly I-C | 1 | 2018 | 58 | 0.130 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 441 | 0.130 |
Why?
| | Staphylococcal Skin Infections | 2 | 2010 | 40 | 0.130 |
Why?
| | Models, Biological | 3 | 2015 | 1763 | 0.130 |
Why?
| | Granulocyte-Macrophage Progenitor Cells | 1 | 2017 | 4 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 477 | 0.130 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2019 | 382 | 0.130 |
Why?
| | Cell Self Renewal | 1 | 2017 | 52 | 0.120 |
Why?
| | Intervertebral Disc | 1 | 2017 | 36 | 0.120 |
Why?
| | Heart Diseases | 1 | 2020 | 341 | 0.120 |
Why?
| | Neutrophil Infiltration | 2 | 2007 | 104 | 0.120 |
Why?
| | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2006 | 5 | 0.120 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2020 | 881 | 0.120 |
Why?
| | Antineoplastic Agents | 4 | 2020 | 2207 | 0.120 |
Why?
| | Blood Platelets | 1 | 2019 | 379 | 0.120 |
Why?
| | Lymphoid Progenitor Cells | 1 | 2015 | 11 | 0.110 |
Why?
| | Myeloid Progenitor Cells | 1 | 2015 | 16 | 0.110 |
Why?
| | RNA Splicing | 3 | 2023 | 284 | 0.110 |
Why?
| | Thrombosis | 1 | 2019 | 401 | 0.110 |
Why?
| | Bone Marrow Transplantation | 1 | 2016 | 297 | 0.110 |
Why?
| | Cell Division | 1 | 2016 | 753 | 0.110 |
Why?
| | Mice, Congenic | 1 | 2014 | 23 | 0.100 |
Why?
| | Resting Phase, Cell Cycle | 1 | 2014 | 16 | 0.100 |
Why?
| | Primary Myelofibrosis | 1 | 2013 | 8 | 0.100 |
Why?
| | Cell Cycle Checkpoints | 1 | 2014 | 97 | 0.100 |
Why?
| | Myeloproliferative Disorders | 1 | 2013 | 21 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2006 | 425 | 0.100 |
Why?
| | Primates | 2 | 2024 | 133 | 0.090 |
Why?
| | TNF Receptor-Associated Factor 3 | 3 | 2007 | 5 | 0.090 |
Why?
| | Cell Survival | 2 | 2014 | 1100 | 0.090 |
Why?
| | DNA Replication | 1 | 2014 | 249 | 0.090 |
Why?
| | Cellular Senescence | 1 | 2014 | 226 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2018 | 873 | 0.090 |
Why?
| | Transcription Factors | 2 | 2018 | 1731 | 0.090 |
Why?
| | Embryo, Mammalian | 1 | 2011 | 234 | 0.080 |
Why?
| | Chemokine CCL2 | 1 | 2011 | 112 | 0.080 |
Why?
| | Tularemia | 1 | 2011 | 30 | 0.080 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 127 | 0.080 |
Why?
| | Megakaryocytes | 2 | 2020 | 34 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2025 | 407 | 0.080 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 532 | 0.080 |
Why?
| | Gene Deletion | 1 | 2011 | 391 | 0.070 |
Why?
| | Male | 11 | 2025 | 72664 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 447 | 0.070 |
Why?
| | Interleukin-17 | 1 | 2010 | 120 | 0.070 |
Why?
| | Spleen | 1 | 2011 | 507 | 0.070 |
Why?
| | Receptors, Interleukin-1 | 2 | 2007 | 211 | 0.070 |
Why?
| | Cell Line | 5 | 2021 | 2821 | 0.070 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2007 | 16 | 0.070 |
Why?
| | Dinucleoside Phosphates | 1 | 2007 | 31 | 0.070 |
Why?
| | Endopeptidases | 1 | 2007 | 80 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2008 | 165 | 0.060 |
Why?
| | Skin | 2 | 2010 | 753 | 0.060 |
Why?
| | Interleukin-6 | 1 | 2011 | 775 | 0.060 |
Why?
| | RNA Viruses | 1 | 2008 | 73 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2025 | 917 | 0.060 |
Why?
| | Caspases | 2 | 2005 | 233 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4282 | 0.060 |
Why?
| | Antibody Formation | 1 | 2007 | 287 | 0.060 |
Why?
| | RNA, Double-Stranded | 1 | 2006 | 51 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2019 | 858 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 50 | 0.060 |
Why?
| | Interleukin-15 | 1 | 2025 | 95 | 0.050 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 499 | 0.050 |
Why?
| | Female | 8 | 2025 | 78636 | 0.050 |
Why?
| | Listeria monocytogenes | 1 | 2006 | 102 | 0.050 |
Why?
| | Receptor, Notch1 | 1 | 2025 | 63 | 0.050 |
Why?
| | Toll-Like Receptors | 1 | 2006 | 193 | 0.050 |
Why?
| | Organophosphorus Compounds | 1 | 2025 | 84 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2025 | 440 | 0.050 |
Why?
| | Staphylococcal Infections | 1 | 2007 | 390 | 0.050 |
Why?
| | Chemotaxis | 1 | 2023 | 122 | 0.050 |
Why?
| | Bone Marrow Cells | 3 | 2011 | 320 | 0.050 |
Why?
| | Immunophenotyping | 1 | 2024 | 318 | 0.050 |
Why?
| | Thrombopoiesis | 1 | 2022 | 7 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2004 | 506 | 0.050 |
Why?
| | RNA, Viral | 1 | 2006 | 690 | 0.050 |
Why?
| | Germ Cells | 1 | 2022 | 65 | 0.040 |
Why?
| | Apoptosis Regulatory Proteins | 3 | 2008 | 187 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2022 | 186 | 0.040 |
Why?
| | Time-Lapse Imaging | 1 | 2021 | 21 | 0.040 |
Why?
| | Mice, SCID | 1 | 2022 | 369 | 0.040 |
Why?
| | Leukemia, Myelomonocytic, Acute | 1 | 2021 | 6 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1763 | 0.040 |
Why?
| | Environmental Exposure | 1 | 2025 | 577 | 0.040 |
Why?
| | Candidiasis | 1 | 2021 | 64 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 613 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2021 | 408 | 0.040 |
Why?
| | DNA Methylation | 1 | 2025 | 667 | 0.040 |
Why?
| | Cell Movement | 1 | 2004 | 959 | 0.040 |
Why?
| | Adoptive Transfer | 1 | 2020 | 199 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 977 | 0.040 |
Why?
| | Fetus | 1 | 2024 | 804 | 0.040 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2019 | 23 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 48 | 0.040 |
Why?
| | K562 Cells | 1 | 2019 | 92 | 0.040 |
Why?
| | Protein Transport | 1 | 2020 | 441 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2019 | 117 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 99 | 0.040 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 108 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 740 | 0.040 |
Why?
| | Lymphopoiesis | 1 | 2018 | 27 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 84 | 0.030 |
Why?
| | Antigens, CD | 1 | 2021 | 558 | 0.030 |
Why?
| | Fluorouracil | 1 | 2019 | 230 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3338 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 267 | 0.030 |
Why?
| | Cohort Studies | 2 | 2020 | 5988 | 0.030 |
Why?
| | NF-kappa B | 3 | 2007 | 664 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2019 | 396 | 0.030 |
Why?
| | Granulocytes | 1 | 2017 | 81 | 0.030 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 302 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2017 | 57 | 0.030 |
Why?
| | T-Lymphocytes | 2 | 2018 | 1993 | 0.030 |
Why?
| | Interferon-alpha | 2 | 2007 | 193 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 820 | 0.030 |
Why?
| | Osteogenesis | 1 | 2017 | 204 | 0.030 |
Why?
| | Caspase 8 | 2 | 2005 | 47 | 0.030 |
Why?
| | beta Catenin | 1 | 2017 | 254 | 0.030 |
Why?
| | Fas Ligand Protein | 2 | 2005 | 60 | 0.030 |
Why?
| | Minichromosome Maintenance Proteins | 1 | 2014 | 6 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 618 | 0.030 |
Why?
| | DNA, Ribosomal | 1 | 2014 | 84 | 0.030 |
Why?
| | Thrombopoietin | 1 | 2013 | 5 | 0.020 |
Why?
| | Cell Transdifferentiation | 1 | 2013 | 31 | 0.020 |
Why?
| | Chemokine CCL3 | 1 | 2013 | 26 | 0.020 |
Why?
| | Protein Binding | 1 | 2018 | 2235 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2351 | 0.020 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2011 | 41 | 0.020 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2011 | 68 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2011 | 80 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2013 | 474 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3138 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 36126 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7182 | 0.020 |
Why?
| | Histones | 1 | 2014 | 665 | 0.020 |
Why?
| | Hematologic Neoplasms | 1 | 2011 | 168 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2008 | 115 | 0.020 |
Why?
| | Interleukins | 1 | 2010 | 248 | 0.020 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2007 | 22 | 0.020 |
Why?
| | Toll-Like Receptor 3 | 1 | 2007 | 30 | 0.020 |
Why?
| | Risk Factors | 1 | 2022 | 10857 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2007 | 57 | 0.020 |
Why?
| | STAT1 Transcription Factor | 1 | 2007 | 66 | 0.020 |
Why?
| | Ubiquitin | 1 | 2007 | 83 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 239 | 0.020 |
Why?
| | Neutrophil Activation | 1 | 2007 | 84 | 0.020 |
Why?
| | Ubiquitination | 1 | 2007 | 118 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2007 | 219 | 0.020 |
Why?
| | Cytoskeletal Proteins | 1 | 2007 | 156 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 498 | 0.020 |
Why?
| | Sendai virus | 1 | 2006 | 6 | 0.020 |
Why?
| | DNA Primers | 1 | 2007 | 505 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2010 | 784 | 0.020 |
Why?
| | Intracellular Fluid | 1 | 2006 | 25 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 456 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 855 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2007 | 634 | 0.010 |
Why?
| | Death Domain Receptor Signaling Adaptor Proteins | 1 | 2005 | 2 | 0.010 |
Why?
| | Cycloheximide | 1 | 2005 | 42 | 0.010 |
Why?
| | Dactinomycin | 1 | 2005 | 23 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2588 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5886 | 0.010 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2005 | 24 | 0.010 |
Why?
| | Toll-Like Receptor 2 | 1 | 2006 | 125 | 0.010 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2005 | 49 | 0.010 |
Why?
| | Chemokines | 1 | 2006 | 217 | 0.010 |
Why?
| | Caspase Inhibitors | 1 | 2005 | 81 | 0.010 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2004 | 25 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2005 | 254 | 0.010 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 54 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2007 | 496 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2127 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2005 | 762 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2881 | 0.010 |
Why?
| | Phosphorylation | 1 | 2007 | 1706 | 0.010 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2003 | 194 | 0.010 |
Why?
| | Oligopeptides | 1 | 2005 | 266 | 0.010 |
Why?
| | MAP Kinase Signaling System | 1 | 2004 | 307 | 0.010 |
Why?
| | Adult | 1 | 2025 | 40665 | 0.010 |
Why?
| | Alleles | 1 | 2005 | 888 | 0.010 |
Why?
| | Child | 1 | 2020 | 22670 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2005 | 3539 | 0.010 |
Why?
|
|
Pietras's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|